Humacyte, Inc. (HUMA)
NASDAQ · Healthcare
Humacyte, Inc. Operating Income 2024–2025
Humacyte, Inc. annual/quarterly operating income history and growth rate from 2024 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Humacyte, Inc. operating income for the quarter ending March 31, 2026 was -28.9 M, a 24.81% increase year-over-year.
- Humacyte, Inc. operating income for the twelve months ending March 31, 2026 was -106.2 M, a 0.58% decrease year-over-year.
- Humacyte, Inc. annual operating income for 2025 was -108.1 M, a 5.47% decrease from 2024.
- Humacyte, Inc. annual operating income for 2024 was -114.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Humacyte, Inc. Operating Income — FAQ
Humacyte, Inc. (HUMA) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Humacyte, Inc.'s operating income?
Humacyte, Inc. (HUMA) reported operating income of -$108M for fiscal 2025.
Where can I see HUMA's operating income history?
The chart and table above show Humacyte, Inc.'s operating income by year and by quarter, including the growth rate.